Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-15

Clinical Trial Update: Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic Inpatients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing degludec/liraglutide versus insulin basal bolus in type 2 diabetes inpatients, focusing on time in range, inflammation, and endothelial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Degludec/Liraglutide (degludec/liraglutide)
  • Insulin basal bolus (insulin basal bolus)

Snippet

Sponsor: University of Palermo | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED